Investors
3 investorsAll
Early stage
Mid stage
Late stage
Early stage· 3
Yves Dudal
CEO | Perseo pharma | Restoring digestive function through novel GI biologics | Bridging gastrointestinal therapeutics and healthy ageing
CEO and Board member
early stage
2 investments
Mar 2019
Werner Enz
Experienced C- and Board level life sciences Executive
Board Member
early stage
3 investments
Mar 2019
Martin Riediker
Chairman of the Board of Directors INOFEA AG
Member of the Board
early stage
13 investments
Mar 2019
Investor geography1 country
Frequently asked questions
Who invested in Perseo pharma AG?
Perseo pharma AG has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Perseo pharma AG last raise funding?
The most recent investment in Perseo pharma AG recorded on gritt.io was in March 2019.
When was Perseo pharma AG founded?
Perseo pharma AG was founded in 2019.
What industry is Perseo pharma AG in?
Perseo pharma AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Perseo pharma AG based?
Perseo pharma AG is headquartered in Basel, Switzerland.
